Delivery Order HHSN261201600005I-75N91018F00004

<p>This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to Miedzynarodowy Instytut Onkologii Molekularnej, a foundation located in Poznań, Poland. The contract is valued at $475,433.33 and has an ultimate completion date of September 17, 2018. The contract is part of the Tissue Source Site for Tumor Analysis master indefinite-delivery, indefinite-quantity (IDIQ) contract. The contract does not have a set-aside designation.</p>

This is a firm-fixed-price delivery order awarded by the National Cancer Institute (NCI) to Miedzynarodowy Instytut Onkologii Molekularnej, a foundation located in Poland. The contract is for Tissue Source Site (TSS) services in support of NCI's Clinical Proteomic Tumor Analysis Consortium, specifically for the analysis of 100 cases across Payments 1-3 at a rate of $2,000 per case (with an 85% payment factor). The total ceiling value of the contract is $402,700. This delivery order is part of...

The National Cancer Institute (NCI) awarded a $71,250.00 Firm Fixed Price Delivery Order to the Miedzynarodowy Instytut Onkologii Molekularnej, a foundation located in Poland, for medical images of biospecimens under the Tissue Source Site for Tumor Analysis contract vehicle. The work is part of the NCI's CPTAC (Clinical Proteomic Tumor Analysis Consortium) program, which focuses on generating and analyzing comprehensive clinical proteomic data for cancer research. This contract does not have...

This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Istituto Superiore DI Sanita' - ISS, a foreign government entity in Italy. The contract, valued at $79,994.00, is for extending code and methods to provide estimates by phases of care (MIAMOD/PIAMOD). The contract does not have a set-aside designation and the ultimate completion date is February 28, 2018. ISS has...

This is a Delivery Order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Melanoma Institute Australia, a foreign-owned non-profit organization. The contract is for $192,500.00 and is related to the NCI Cancer Genome Atlas Program, which involves the collection of tissue samples and data from various types of cancer. There is no set-aside designation for this contract. The contract is a Firm Fixed Price type and has an ultimate completion date of September 30, 2014....

This is a delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The $1,725 firm fixed price order is for a contract orientation meeting and is part of a larger $146.3 million IDIQ contract between IITRI and the National Institute of Allergy and Infectious Diseases (NIAID) for preclinical models of infectious diseases. IITRI has...

This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract, valued at $95,509.00, is for the procurement of one (1) I-DOT 2.0 dispensing system for the preparation of next-generation sequencing (NGS) library preps of T-cell receptors (TCRs) in support of cancer research. The contract was set aside for small businesses, and the prime...

<p>This is a $632,469.60 firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Biopartners, Inc. The contract supports the Tissue Source Site for Tumor Analysis program and has a final completion date of September 4, 2021. There was no set-aside designation for this award. The contract does not mention any major subcontractors.</p>

This is a federal contract award from the Department of Health and Human Services National Institutes of Health National Cancer Institute to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract, valued at $67,882,919.00, is a cost-plus-fixed-fee delivery order for the PDX PANELS FROM COMMON TUMORS project. The work is to be performed at the Fort Detrick facility in Maryland and has a completion date of September 25, 2027. The contract does not have a set-aside...

<p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $17,640 purchase order to Human Metabolome Technologies America, Inc. for testing services. The firm fixed price contract will be performed in Boston, Massachusetts over a three month period concluding in October 2023. The award provides testing services in support of the National Cancer Institute's research efforts. No subcontractors or set aside designations were identified.</p>